A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SSRIs / selective serotonin reuptake inhibitors

[Related PubMed/MEDLINE]
Total Number of Papers: 3758
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SSRIs  (>> Co-occurring Abbreviation)
Long Form:   selective serotonin reuptake inhibitors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns. ---
2019 A review of N-acetylcysteine in the treatment of groomingdisorders. NAC
2019 Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain. RSNs
2019 Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons. iPSCs, MDD, NR
2019 An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis. CS, lOFC, MSNs, OCD, QNP
2019 An updated review on pathophysiology and management of burning mouth syndrome with endocrinological, psychological and neuropathic perspectives. BMS, SNRIs
2019 Animal models of post-traumatic stress disorder and novel treatment targets. PTSD
2019 Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. ---
2019 Antidepressants are modifiers of lipid bilayer properties. gA, ITC, TCAs
10  2019 Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study. FOG, PD, QIDS-J, SNRIs
11  2019 Antidepressants in surface waters: fluoxetine influences mosquitofish anxiety-related behavior at environmentally relevant levels. ---
12  2019 Antipsychotic augmentation in the treatment of obsessive-compulsive disorder. ---
13  2019 Are neuropeptides relevant for the mechanism of action of SSRIs? ---
14  2019 Benzodiazepines versus placebo for panic disorder in adults. CENTRAL, CI, NNTB, RR, SMD
15  2019 Buprenorphine for the treatment of posttraumatic stress disorder. KOR, PTSD
16  2019 Changes in white matter and the effects of fluoxetine on such changes in the CUS rat model of depression. SD
17  2019 Chronic fluoxetine treatment of juvenile zebrafish (Danio rerio) does not elicit changes in basal cortisol levels and anxiety-like behavior in adulthood. dpf, ELISA
18  2019 Citalopram attenuates social behavior deficits in the BTBR T+Itpr3tf/J mouse model of autism. ASD
19  2019 Citalopram-Associated Alopecia: A Case Report and Brief Literature Review. ---
20  2019 Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus. ---
21  2019 Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. ---
22  2019 Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions. gMPs
23  2019 CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study. CYP2C19, NM, PK, PMs, RM, UM
24  2019 Developmental outcomes after gestational antidepressant treatment with sertraline and its discontinuation in an animal model of maternal depression. ---
25  2019 Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. ---
26  2019 Effect of monoamine reuptake inhibition and alpha1 blockade on respiratory arrest and death following electroshock-induced seizures in mice. MES, NE, NRIs, S-IRA, SUDEP, WT
27  2019 Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study. CAD, CI, DAPT, HR, MACE, PCI
28  2019 Effectiveness and safety of fluoxetine for premature ejaculation: Protocol for a systematic review. AIPE, CBMdisc, CNKI, IELT, IPE, PE, PEDT
29  2019 Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review. 22q11.2DS, ADHD, SAMe
30  2019 Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. ---
31  2019 Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis. IFN, IL, MDD, TNF
32  2019 Effects of two selected SSRIs on hemorheological parameters in rats. AMP, CVDs
33  2019 Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis. CrI, OR, SNRI
34  2019 Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial. CGI-I, OCD, pre-SMA, tDCS, Y-BOCS
35  2019 Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. CNS
36  2019 Fluoxetine Modulates Spontaneous and Conditioned Behaviors to Carbon Dioxide (CO2) Inhalation and Alters Forebrain-Midbrain Neuronal Activation. PAG, PD
37  2019 Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects. ---
38  2019 Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder. OCD
39  2019 Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment. ---
40  2019 Hypochondriasis: Clinical Profile in a Tertiary Care Psychiatry and Neurosciences Hospital in Southern India - A Retrospective Chart Review. DCPR, IAD
41  2019 In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning. ---
42  2019 In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis. CI, HR, PRISMA
43  2019 In vivo effects of serotonin and fluoxetine on cardio-ventilatory functions in the shore crab Carcinus maenas (L. 1758). ---
44  2019 Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late-life depression. ALFF, dmPFC, FC, FDR, LLD, MADRS, MDD, ROI, vmPFC
45  2019 Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders. ---
46  2019 Integrin alphaVbeta3 Function Influences Citalopram Immobility Behavior in the Tail Suspension Test. ---
47  2019 Interactions of Selective Serotonin Reuptake Inhibitors with beta-Amyloid. AD
48  2019 Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review. SNRIs
49  2019 Manual or electroacupuncture as an add-on therapy to SSRIs for depression: A randomized controlled trial. AEs, CGI, EA, MA, SDS
50  2019 Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake. FG, SERT, SG
51  2019 Non-Fatal Intoxication with a High Dose of Citalopram in a Suicidal 14-Year-Old Girl. ---
52  2019 Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. ---
53  2019 Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. BUP, MDD, SAM
54  2019 Oromandibular Dystonia Related to Sertraline Treatment in a Child. ---
55  2019 Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. IELT, PDE5Is, PE, RCTs
56  2019 Paroxetine Induces Apoptosis of Human Breast Cancer MCF-7 Cells through Ca2+-and p38 MAP Kinase-Dependent ROS Generation. ROS
57  2019 Perinatal fluoxetine has enduring sexually differentiated effects on neurobehavioral outcomes related to social behaviors. HPA, pSSRI
58  2019 Plasma serotonin levels are associated with antidepressant response to SSRIs. MDD
59  2019 Postnatal outcomes in lambs exposed antenatally and acutely postnatally to fluoxetine. FX, HRV, i.v
60  2019 Potentiation of serotonin signaling protects against intestinal ischemia and reperfusion injury in mice. I/R, SERT, SERT, SMA, WTLM
61  2019 Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose. SES
62  2019 Predicting inadequate postoperative pain management in depressed patients: A machine learning approach. AUC, NLP
63  2019 Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice. mPFC, SSRI
64  2019 Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks. GIBP
65  2019 Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa. BED, BN
66  2019 Response to sertraline is influenced by GNbeta3 gene G-350A variant in patients with major depressive disorder. G proteins, GNbeta3, HRSD, MDD
67  2019 Selective serotonin reuptake inhibition increases noise burst-induced unconditioned and context-conditioned freezing. ---
68  2019 Selective serotonin reuptake inhibitor fluvoxamine ameliorates stress- and NSAID-induced peptic ulcer possibly by involving Hsp70. HSP70, NSAIDs
69  2019 Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding. ---
70  2019 Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study. CCI, CIs, PRRs
71  2019 Selective Serotonin Reuptake Inhibitors Aggravate Depression-Associated Dry Eye Via Activating the NF-kappaB Pathway. DED
72  2019 Selective Serotonin Reuptake Inhibitors and Fertility: Considerations for Couples Trying to Conceive. ---
73  2019 Serotonin and motherhood: From molecules to mood. ---
74  2019 Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. iPSCs, MDD
75  2019 Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor. NGF
76  2019 Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation. ---
77  2019 Skin-Picking Disorder: A Guide to Diagnosis and Management. ---
78  2019 Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept. 5-HTP, IR, SR
79  2019 SSRI co-medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010-2015. NOACs, VKAs
80  2019 SSRIs target prefrontal toraphe circuits during development modulating synaptic connectivity and emotional behavior. DRN, PFC
81  2019 Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. SNRIs
82  2019 Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression. SERT
83  2019 The association between antidepressant use and deaths from road traffic accidents: a case-crossover study. OR, SNRIs
84  2019 The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression. CAD, MDD, PGS, PT
85  2019 The dynamic serotonin system of the maternal brain. ---
86  2019 The effect of selective serotonin reuptake inhibitors in healthy subjects revisited: A systematic review of the literature. ---
87  2019 The effect of selective serotonin reuptake inhibitors on major adverse cardiovascular events: a meta-analysis of randomized-controlled studies in depression. CI, MACE, RCTs, RR, RRs
88  2019 Tissue regulatory T cells and neural repair. AREG
89  2019 Towards Improving Post-SSRI Sexual Dysfunction by Using Nutriceuticals: Lessons from a Case Study. ---
90  2019 Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: a population-based retrospective cohort study in Australia. ADHD
91  2019 Trick or treat? Evaluating contributing factors and sex-differences for developmental effects of maternal depression and its treatment. ---
92  2019 Use of antidepressants after colon cancer diagnosis and risk of recurrence. CI, HR, TCAs
93  2018 A 12-week Comparative Prospective Open-label Randomized Controlled Study in Depression Patients Treated with Vilazodone and Escitalopram in a Tertiary Care Hospital in North India. ASEX, HDRS
94  2018 A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age. LBW, SGA
95  2018 A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects. IGF1
96  2018 Activation of 5-HT2C (but not 5-HT1A) receptors in the amygdala enhances fear-induced antinociception: Blockade with local 5-HT2C antagonist or systemic fluoxetine. EPM, OAA
97  2018 Acupuncture and acupressure for premenstrual syndrome. CBM, CI, CNKI, DRSP, ISPMD, MD, PMDD, PMS, RCT, RR
98  2018 Acute and chronic escitalopram alter EEG gamma oscillations differently: relevance to therapeutic effects. EEG, IS, REMS
99  2018 Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review. SNRIs, TCAs
100  2018 Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study. DBPC, dTMS, MT